Markedsdata leveret af TwelveData og Morningstar
Interpace Biosciences Inc. is a distinguished healthcare and diagnostics-focused biotechnology company. It primarily specializes in offering molecular diagnostic tests and pathology services that enable pathology and oncology professionals to identify and characterize various medical conditions, including cancers. The company's specialty lies in its advancement of molecular testing capabilities, which are crucial in areas like endocrinology and gastroenterology. Interpace Biosciences serves a vital role in the medical industry by providing unique diagnostic solutions that aid physicians in making informed decisions about patient care and potentially improving outcomes. Headquartered in the United States, Interpace Biosciences leverages its technological prowess and proprietary platforms to contribute significantly to the healthcare diagnostics sector, thereby enhancing the precision of medical testing across various health conditions.